Intratumor Heterogeneity and Therapy Resistance: Contributions of Dormancy, Apoptosis Reversal (Anastasis) and Cell Fusion to Disease Recurrence
A major challenge in treating cancer is posed by intratumor heterogeneity, with different sub-populations of cancer cells within the same tumor exhibiting therapy resistance through different biological processes. These include therapy-induced dormancy (durable proliferation arrest through, e.g., po...
Main Authors: | Razmik Mirzayans, David Murray |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/4/1308 |
Similar Items
-
Do TUNEL and Other Apoptosis Assays Detect Cell Death in Preclinical Studies?
by: Razmik Mirzayans, et al.
Published: (2020-11-01) -
Cellular Responses to Platinum-Based Anticancer Drugs and UVC: Role of p53 and Implications for Cancer Therapy
by: David Murray, et al.
Published: (2020-08-01) -
Roles of Polyploid/Multinucleated Giant Cancer Cells in Metastasis and Disease Relapse Following Anticancer Treatment
by: Razmik Mirzayans, et al.
Published: (2018-04-01) -
Anastasis: Return Journey from Cell Death
by: Victoria Zaitceva, et al.
Published: (2021-07-01) -
Anastasis: recovery from the brink of cell death
by: Ho Man Tang, et al.
Published: (2018-01-01)